MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202411093538 A) filed by Lovely Professional University on November 29, 2024, for Broccoli Extract-Based Hydrogel For Transdermal Breast Cancer Therapy: A Controlled Drug Delivery System.
Inventors include Kajal; and Dr Minhaj Ahmad Khan.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The invention relates to the development of a broccoli extract-based hydrogel for transdermal drug delivery, designed to treat breast cancer. The hydrogel incorporates sulforaphane, a potent anticancer compound found in broccoli, within a biocompatible, water-soluble polymer network that allows for sustained and localized drug release. The transdermal system provides a non-invasive alternative to traditional treatments, such as chemotherapy, by targeting cancer cells directly through the skin while minimizing side effects on healthy tissues. Characterization techniques, including HPLC, GC-MS, and LC-MS, confirm the presence and concentration of sulforaphane in the broccoli extract. The hydrogel's anticancer activity is evaluated through in vitro studies using breast cancer cell lines (MCF-7, MDA-MB-231) and in vivo mouse models, demonstrating significant tumor reduction and improved safety. This novel delivery system offers a controlled release, environmentally friendly, and patient-compliant approach for the treatment of breast cancer, with potential for broader application in oncology
Disclaimer: Curated by HT Syndication.
